Show Summary Details
Page of

Cannabis, Nicotine, and Stimulant Abuse in Older Adults 

Cannabis, Nicotine, and Stimulant Abuse in Older Adults
Chapter:
Cannabis, Nicotine, and Stimulant Abuse in Older Adults
Author(s):

Christina A. Brezing

and Frances R. Levin

DOI:
10.1093/med/9780199392063.003.0006
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 June 2019

In conjunction with alcohol, cannabis, nicotine, and stimulants are the substances most commonly used by older adults. Little is known about the specific characteristics of older adults who use these substances and how best to screen, identify, and treat these disorders in this population. As we reach the population peak for aging baby boomers, increasing percentages of older adults are using these substances, and developing substance-use disorders is anticipated. Concomitant factors are policy and social changes toward drugs of abuse in the United States. Evidence presented in this chapter represents what is currently known about cannabis, nicotine, and stimulant use and its impact on older adults. However, the use of these substances in older adults is under-studied, and much of the current information is extrapolated from studies of younger and middle-aged adults. This practice represents a large gap in our understanding and a significant opportunity for future research endeavors.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.